Working titles shown. Final titles will be announced.
Wednesday, December 8, 2010
2:00 PM - 7:30 PM
EDUCATIONAL SESSIONS
Ballroom C
An update on advances in the technologies available for translational research. Sessions are to provide people with a better understanding of the talks they hear using the techniques described. They also provide researchers with a guide to the techniques they should be considering for their studies.
CNS metastases in breast cancer
Moderator: Nancy U. Lin, MD
Dana Farber Cancer Institute
Boston, MA
Genetic testing
Moderator: Mark E. Robson, MD
Memorial Sloan Kettering
New York, NY
Emerging Radiation Techniques – The Fast and the Furious
Moderator: Richard Crownover, MD, PhD
UT Health Science Center San Antonio
San Antonio, TX
Rationale and Results of Accelerated Partial Breast Irradiation
Frank A. Vicini, MD
William Beaumont Hospital
Royal Oak, MI
Radiosurgery and Stereotactic Body Radiotherapy
Richard Crownover, MD, PhD
UT Health Science Center San Antonio
San Antonio, TX
Symptom Management
Moderator: Laura Esserman, MD, MBA
University of California San Francisco
San Francisco, CA
Design & Interpretation of Biomarker Studies
Moderator: Mitchell Dowsett, MD, PhD
Royal Marsden Hospital NHS Trust
London, UNITED KINGDOM
Design and statistical issues for biomarker studies
Lisa M. McShane, PhD
National Cancer Institute
Bethesda, MD
The importance of technical validation
Jorge Reis-Filho
, MD, PhD, MRCPath
Breakthrough Breast Cancer Research Center
The Institute of Cancer Research
London, UNITED KINGDOM
Interpretation of biomarker studies
Lajos Pusztai MD, DPhil
UT MD Anderson Cancer Center
Houston, TX
DNA Repair
Moderator: Daniel P. Silver, MD, PhD
Dana Farber Cancer Institute
Boston, MA
DNA Repair Pathways and Tumorigenesis
James M. Ford, MD
Stanford University Medical Center
Stanford, CA
DNA Repair and Breast Cancer: Therapeutic Opportunities and Challenges
Daniel P. Silver, MD, PhD
Dana Farber Cancer Institute
Boston, MA
Automated, quantitative cell and tissue imaging technologies
Moderator: Rachel Schiff, PhD
Baylor College of Medicine
Houston, TX
Title TBA
Peter Sorger, PhD
Harvard Medical School
Boston, MA
Title TBA
David L. Rimm, MD, PhD
Yale University School of Medicine
New Haven, CT
Next Generation Sequencing
Moderator: Charles Perou, PhD
University of North Carolina
Chapel Hill, NC
Title TBD
Elaine R. Mardis, PhD
Washington University
St. Louis, MO
Title TBD
Andy Futreal, PhD
Wellcome Trust Sanger Institute
Cambridge, UNITED KINGDOM
Next Generation Sequencing for Gene Expression Profiling
Charles Perou, PhD
University of North Carolina
Chapel Hill, NC
Systems Biology
Moderator: Adrian Lee, PhD
Baylor College of Medicine
Houston, TX
AWARD LECTURES
Exhibit Hall D
AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure®
Susan G. Komen for the Cure Brinker Awards for Scientific Distinction Lectures
AACR Distinguished Lectureship in Breast Cancer Research
Alan Ashworth, PhD, FMedSci, FRS
Breakthrough Research Centre at
The Institute of Cancer Research
London, UNITED KINGDOM
William L. McGuire Memorial Lecture
George W. Sledge, Jr., MD
Indiana University Cancer Center
Indianapolis, IN
PLENARY LECTURES
Exhibit Hall D
Drug Development – targeting HER2 beyond trastuzumab
Neil Spector, MD
Duke University Medical Center
Durham, NC
Decision-making
Dan Ariely, PhD
Duke University
Durham, NC
MINI-SYMPOSIA
Exhibit Hall D
noncodingRNA- the new frontier
Moderator: Saraswati Sukumar, PhD
Johns Hopkins Oncology Center
Baltimore, MD
Title TBD
Howard Chang, MD, PhD
Stanford School of Medicine
Stanford, CA
MicroRNA in medical practice
George A. Calin, MD, PhD
UT MD Anderson Cancer Center
Houston, TX
Surgery
Moderator: Ismail Jatoi, MD, PhD, FACS
UT Health Science Center San Antonio
San Antonio, TX
Surgical Considerations in Early Breast Cancer
Lisa Newman, MD MPH, FACS
University of Michigan
Ann Arbor, MI
Recent U.S. Trends in the Surgical Management of Primary Breast Cancer
Todd Tuttle, MD
University of Minnesota
Minneapolis, MN
Modern Breast Reconstructive Techniques
Jean-Yves Petit
European Institute of Surgical Oncology
Milan, ITALY
Breast disparities
Moderator: Amelie Ramirez, DrPH, MPH
UT Health Science Center San Antonio
San Antonio, TX
THE YEAR IN REVIEW
Sunday, December 12, 2010
Exhibit Hall D
BASIC SCIENCE FORUMS - Lunchtime Sessions
Ballroom B
Stem cells- defying definition?
Moderator: Jorge Reis-Filho, MD, PhD, MRCPath
Breakthrough Breast Cancer Research Center
The Institute of Cancer Research
London, UNITED KINGDOM
Title TBD
Michael F. Clarke, MD
Stanford School of Medicine
Stanford, CA
Title TBD
Jane Visvader, PhD
Walter and Eliza Hall Institute of Medical Research
Parkville, AUSTRALIA
Novel survival pathways, hypoxia
Moderator: C. Kent Osborne, MD
Baylor College of Medicine
Houston, TX
Tumor dormancy – What is it? Does it matter?
Moderator: Lewis A. Chodosh, MD, PhD
University of Pennsylvania School of Medicine
Philadelphia, PA
CLINICAL SCIENCE FORUM - Lunchtime Sessions
Ballroom A
Controversies in screening for breast cancer
Moderator: Eric Winer, MD
Dana Farber Cancer Institute
Boston, MA
CASE DISCUSSIONS - Lunchtime Sessions
Ballroom A
CAREER DEVELOPMENT FORUM
Ballroom A
The session is open to early-career scientists, defined as graduate students, postdoctoral or clinical fellows, or medical students and residents, who are registered attendees of the SABCS. Space in the workshop is limited to 135 participants; registrations will be accepted on a first-come, first-served basis and is free of charge. Registration information will be available in mid-2010.